Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of noninvasive near-infrared spectroscopy with outcomes in pediatric traumatic brain injury.

Journal of neurosurgery. Pediatrics·2026
Same author

Tumor Microenvironmental Regulation of CAR T-Cell Therapy in High Risk Medulloblastoma.

Research square·2026
Same author

Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study.

Pediatric blood & cancer·2026
Same author

Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas.

Radiology. Artificial intelligence·2026
Same author

Fascia-Fat-Fascia "Sandwich Graft" Decreases Postoperative Cerebrospinal Fluid Leak Rate for High-Flow Skull Base Defects.

International forum of allergy & rhinology·2026
Same author

A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma.

Cell reports. Medicine·2026

Related Experiment Video

Updated: Jun 18, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.6K

A transcriptome-based classifier to determine molecular subtypes in medulloblastoma.

Komal S Rathi1,2,3, Sherjeel Arif1,2,3, Mateusz Koptyra1,3

  • 1Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.

Plos Computational Biology
|October 29, 2020
PubMed
Summary

A new transcriptomic classifier accurately identifies medulloblastoma molecular subtypes in children. This tool aids researchers and clinicians in classifying this pediatric brain tumor, improving diagnostic precision.

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.4K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.3K

Related Experiment Videos

Last Updated: Jun 18, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.6K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.4K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.3K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Medulloblastoma is a heterogeneous pediatric brain tumor with five WHO-defined molecular subtypes.
  • Current classification relies on immunostaining, methylation, or genetic analysis.

Purpose of the Study:

  • To develop and validate a robust transcriptomic classifier for medulloblastoma molecular subtypes.
  • To create an accessible R package and Shiny Application for user-friendly classification.

Main Methods:

  • Literature survey to identify RNA-Seq and microarray datasets.
  • Development of a classifier using gene ratios from a composite microarray and RNA-Seq datasets.
  • Utilized limma R package for feature identification and normalized scores for classification.

Main Results:

  • The classifier achieved a median accuracy of 97.8% across 15 independent datasets.
  • Minimum accuracy was 85.71%, with 100% accuracy in four datasets.
  • Most misclassifications occurred between Group 3 and Group 4 subtypes.

Conclusions:

  • A robust transcriptomic classifier for medulloblastoma subtypes has been developed.
  • The R package and Shiny Application provide accessible tools for classification.
  • This classifier is expected to have broad applicability in cancer research and clinical settings.